Eupraxia Pharmaceuticals Inc. (EPRX)

Eupraxia Pharmaceuticals Statistics

Total Valuation

EPRX has a market cap or net worth of $284.22 million. The enterprise value is $294.39 million.

Market Cap	284.22M
Enterprise Value	294.39M

Important Dates

The next estimated earnings date is Friday, November 7, 2025, after market close.

Earnings Date	Nov 7, 2025
Ex-Dividend Date	n/a

Share Statistics

EPRX has 50.60 million shares outstanding. The number of shares has increased by 21.81% in one year.

Current Share Class	50.60M
Shares Outstanding	50.60M
Shares Change (YoY)	+21.81%
Shares Change (QoQ)	+0.63%
Owned by Insiders (%)	17.39%
Owned by Institutions (%)	4.88%
Float	39.01M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	13.55
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.72, with a Debt / Equity ratio of 0.00.

Current Ratio	8.72
Quick Ratio	7.60
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-81.82

Financial Efficiency

Return on equity (ROE) is -169.25% and return on invested capital (ROIC) is -93.38%.

Return on Equity (ROE)	-169.25%
Return on Assets (ROA)	-75.00%
Return on Invested Capital (ROIC)	-93.38%
Return on Capital Employed (ROCE)	-138.93%
Revenue Per Employee	n/a
Profits Per Employee	-$890,344
Employee Count	33
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, EPRX has paid $10,179 in taxes.

Income Tax	10,179
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +117.44% in the last 52 weeks. The beta is 1.49, so EPRX's price volatility has been higher than the market average.

Beta (5Y)	1.49
52-Week Price Change	+117.44%
50-Day Moving Average	5.63
200-Day Moving Average	4.46
Relative Strength Index (RSI)	46.54
Average Volume (20 Days)	61,470

Short Selling Information

The latest short interest is 256,174, so 0.51% of the outstanding shares have been sold short.

Short Interest	256,174
Short Previous Month	185,235
Short % of Shares Out	0.51%
Short % of Float	0.66%
Short Ratio (days to cover)	1.36

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-29.14M
Pretax Income	-29.03M
Net Income	-29.38M
EBITDA	-29.01M
EBIT	-29.14M
Earnings Per Share (EPS)	-$0.82

Balance Sheet

The company has $19.77 million in cash and $35,065 in debt, giving a net cash position of $19.73 million or $0.39 per share.

Cash & Cash Equivalents	19.77M
Total Debt	35,065
Net Cash	19.73M
Net Cash Per Share	$0.39
Equity (Book Value)	20.98M
Book Value Per Share	-0.26
Working Capital	20.21M

Cash Flow

In the last 12 months, operating cash flow was -$30.48 million and capital expenditures -$421,859, giving a free cash flow of -$30.90 million.

Operating Cash Flow	-30.48M
Capital Expenditures	-421,859
Free Cash Flow	-30.90M
FCF Per Share	-$0.61

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

EPRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-21.81%
Shareholder Yield	-21.81%
Earnings Yield	-10.34%
FCF Yield	-10.87%

Analyst Forecast

The average price target for EPRX is $11.50, which is 104.99% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$11.50
Price Target Difference	104.99%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-25.92%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1